尿培养药敏报告与门诊抗生素处方的关联:一项队列研究
实验室间药敏报告率差异大(诺氟沙星10.4%至呋喃妥因83.3%)。报告某抗生素药敏与经验性及目标性处方该抗生素的 odds 增加相关(目标窗 aOR 2.98,95%CI 2.07-4.28)。
要点
- 实验室药敏报告率差异大,诺氟沙星仅10.4%报告,呋喃妥因达83.3%。
- 报告某抗生素药敏与目标窗处方该药 odds 增加相关(aOR 2.98)。
- 实验室层面报告比例每增加25%,经验窗处方该药 odds 增加(aOR 1.23)。
核心结论
- 尿培养药敏报告与门诊老年患者经验性和目标性处方该抗生素相关。
主要发现
- 实验室间药敏报告率差异大,诺氟沙星报告率为10.4%(5/48),呋喃妥因为83.3%(40/48)。
- 报告某抗生素药敏与目标窗(培养结果后0-5天)处方该抗生素的 odds 增加相关(aOR 2.98,95%CI 2.07-4.28)。
- 实验室层面报告比例每增加25%,经验窗(培养结果前1-3天)处方该抗生素的 odds 增加(aOR 1.23,95%CI 1.13-1.33)。
临床怎么用
- 实验室可通过选择性报告药敏结果引导尿路感染门诊抗生素的合理选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Selective reporting of antibiotic susceptibility test results may help guide appropriate antibiotic prescribing, particularly for urinary tract infections. Our objective was to describe laboratory urine culture susceptibility reporting practices and to estimate their impact on antibiotic prescribing in outpatients. METHODS: We examined all positive urine cultures with Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis associated with an antibiotic prescription among outpatients over 65 years of age in Ontario, Canada from 2014 through 2017. We evaluated antibiotic prescribing in the empirical window (1-3 days before culture result) and in the directed window (0-5 days after culture result). Unadjusted and adjusted odds ratios were reported to estimate the association between reporting and prescribing. RESULTS: In total 113 780 eligible urine cultures from 48 laboratories were included in the study cohort. Susceptibility reporting practices were highly variable between laboratories, with a range across antibiotics from norfloxacin (n = 5/48, 10.4% reporting) to nitrofurantoin (n = 40/48, 83.3% reporting). Reporting antibiotic susceptibility was associated with increased odds of prescribing that antibiotic in the directed window (aOR 2.98, 95%CI 2.07-4.28). At the laboratory level, the proportion of urine cultures reporting specific antibiotic susceptibility results was also associated with an increase in prescribing of that antibiotic in the empirical window (adjusted OR 1.23, 95%CI 1.13-1.33, per 25% increase in reporting). CONCLUSIONS: Laboratory reporting of antibiotic susceptibility results for urine cultures is associated with empirical and directed prescribing of the reported antibiotics. Laboratories can play an important role in guiding appropriate antibiotic selection for urinary indications.
引用
- Langford BJ, Daneman N, Diong C, et al. Antibiotic susceptibility reporting and association with antibiotic prescribing: a cohort study. Clin Microbiol Infect. 2020. PMID: 33059090. doi:10.1016/j.cmi.2020.10.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。